| dc.creator | Carvalho, Diogo E. L. | |
| dc.creator | Oliveira, Katia M. | |
| dc.creator | Bomfim, Larissa Mendes | |
| dc.creator | Soares, Milena Botelho Pereira | |
| dc.creator | Bezerra, Daniel Pereira | |
| dc.creator | Batista, Alzir A. | |
| dc.creator | Correa, Rodrigo S. | |
| dc.date | 2020-04-07T17:19:25Z | |
| dc.date | 2020-04-07T17:19:25Z | |
| dc.date | 2020 | |
| dc.date.accessioned | 2023-09-26T21:00:52Z | |
| dc.date.available | 2023-09-26T21:00:52Z | |
| dc.identifier | CARVALHO, Diogo E L et al. Derivatives as Building Blocks to Form Ru(II)-Based Complexes with High Cytotoxicity. ACS Omega, v. 5, p. 122-130, 2020. | |
| dc.identifier | 2470-1343 | |
| dc.identifier | https://www.arca.fiocruz.br/handle/icict/40670 | |
| dc.identifier | 10.1021/acsomega.9b01921 | |
| dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8867740 | |
| dc.description | Brazilian Research Agencies: FAPEMIG, FAPESB, FAPESP,
CNPq and CAPES. D.E.L.C. thanks FAPEMIG for a
fellowship, and K.M.O. is supported by a postdoctoral
fellowship grant from CAPES (PNPD program). Also, R.S.C.
would like to thank the financial support provided by PROPP/
UFOP, FAPEMIG (APQ-01674-18), and CNPq (grants
403588/2016-2 and 308370/2017-1). The authors thank the
IFSC-USP (E.E. Castellano and J.A. Ellena) for X-ray
crystallography measurements and the “Laboratório Multiusuário
de Caracterização de Moléculas”/UFOP for the NMR
facilities. | |
| dc.description | Two new Ru(II)-based complexes containing 2-thiouracil derivatives, known as 2-thiouracil (2TU) and 6-methyl-2-thiouracil (6m2TU), were synthesized using cis,trans-[RuCl2(PPh3)2(bipy)] as a precursor. The obtained compounds with a general formula trans-[Ru(2TU)(PPh3)2(bipy)]PF6 (1) and trans-[Ru(6m2TU)(PPh3)2(bipy)]PF6 (2) were characterized by analytical techniques such as NMR, UV-vis, and IR spectroscopies, elementary analysis, mass spectrometry, and single-crystal X-ray diffraction. Moreover, the investigation of the complexes-DNA interaction were carried out using spectrophotometric titrations and showed that the complexes present a weak interaction with this biomolecule. The compounds were evaluated against HL-60, K-562, HepG2, and B16-F10 cancer cells and against noncancer cells (PBMCs). The results of the biological assay revealed that complex 2 is more promising than complex 1. Finally, the present study suggests that complexes 1 and 2 causes cell death by apoptosis, significantly increasing the percentage of apoptotic HL-60 cells, in which the compounds altered the cell cycle, reducing the cells in G1/G0, G2/M, and S phases. | |
| dc.format | application/pdf | |
| dc.language | por | |
| dc.publisher | American Chemical Society: | |
| dc.rights | open access | |
| dc.subject | Proteínas Transportadoras de Nucleobases | |
| dc.subject | Citotoxicidade Imunológica | |
| dc.subject | Pirimidinas | |
| dc.subject | Tratamento Farmacológico | |
| dc.subject | Nucleobase Transport Proteins | |
| dc.subject | Cytotoxicity, Immunologic | |
| dc.subject | Pyrimidines | |
| dc.subject | Drug Therapy | |
| dc.title | Nucleobase Derivatives as Building Blocks to Form Ru(II)-Based Complexes with High Cytotoxicity | |
| dc.type | Article | |